Plain-English translation of NCT02824471 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Sickle Cell Disease research guide →Researchers are testing a new device called a biofluid chip that analyzes blood samples in a simpler, faster way than traditional laboratory methods. Instead of using complicated processes to study your blood cells, this chip works more directly on a tiny surface to capture and count the cells researchers want to study. The goal is to create an easier and more reliable way to monitor sickle cell disease.
Current methods for analyzing blood cells in sickle cell disease are time-consuming, require a lot of processing, and can damage the cells. This study exists to see if the new technology can do the same job faster, more simply, and without harming the cells—which could eventually help doctors monitor your health more easily.
You likely qualify if…
You likely don't qualify if…
If you join this study, you would donate a blood or tissue sample—material that would normally be thrown away after your regular medical care. There is no experimental medication or special procedure involved; researchers simply use your discarded sample to test how well the new chip technology works at analyzing sickle cell disease. Your participation helps researchers develop a potentially simpler tool for monitoring the condition in the future.
AI-generated summary from trial data · Sep 16, 2026 · Not medical advice
United States